BUSINESS, PRESENTATION, AND RECENT ACCOUNTING PRONOUNCEMENTS (Details) $ in Millions, $ in Millions	Jun. 30, 2025 facility product shares	May 22, 2025 shares	May 21, 2025 shares	Dec. 31, 2024 shares	Mar. 28, 2024 USD ($)	Feb. 16, 2024 CAD ($)	Feb. 16, 2024 USD ($)	Feb. 15, 2024 CAD ($)	Feb. 15, 2024 USD ($)
Debt Instrument [Line Items]
Number of new products | product	2
Number of pharmaceutical manufacturing facilities | facility	3
Common Stock
Debt Instrument [Line Items]
Common Stock, shares authorized (in shares) | shares	66,000,000	66,000,000.0	33,300,000	33,333,334
Disposal Group, Held-for-Sale, Not Discontinued Operations | Oakville, Ontario Former Manufacturing Facility
Debt Instrument [Line Items]
Consideration					$ 13.5	$ 19.2	$ 14.2	$ 19.2	$ 14.2